Page URL:

Maternal test for Down's syndrome may reduce need for invasive diagnosis

17 January 2011
Appeared in BioNews 591

New research suggests that Down's syndrome could be detected using genetic screening, avoiding the need for invasive detection procedures.

The study found that it was possible to sequence the DNA collected from blood samples of mothers at high risk of a pregnancy with Down's syndrome. The authors claim that using maternal blood tests would avoid the need for 98 percent of more invasive procedures.

Down's syndrome occurs when there are three copies of either all or part of chromosome 21, instead of the normal two. Individuals with the condition often have learning difficulties.  

The team from the University of Hong Kong compared two 'multiplex' DNA (genetic) sequencing methods in a total of 1,067 pregnancies. These techniques allow the detection of large additions of genetic material that can occur in chromosome 21. They found that the most sensitive method was able to predict Down's syndrome positively in 96.6 percent of cases and negatively in one hundred percent of cases.

Currently Down's syndrome is detected using either amniocentesis or CVS (chorionic villus sampling), which involve taking a sample from the amniotic fluid or placenta respectively, which can increase the risk of miscarriage by around one percent. These tests are still used in three to five percent of pregnancies in the UK, when combination scans and hormone level tests indicate that a mother is at an increased risk of their unborn child developing Down's syndrome.

The scientists concluded that this technique could be used to test for Down's syndrome in high-risk pregnancies, and therefore avoid 98 percent of invasive tests.

The findings were published online in the British Medical Journal (BMJ).

Down's Syndrome Association
Help for people with Down's Syndrome |  18 January 2022
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study
BMJ |  12 January 2011
22 July 2013 - by Dr Lucy Freem 
A method that 'switches off' entire chromosomes has been used in isolated cells to target the genetic defect behind Down's syndrome...
9 July 2012 - by Dr Lux Fatimathas 
US researchers have for the first time sequenced the genome of a fetus using only a blood sample from the mother. It is hoped this new form of non-invasive sampling could allow doctors to screen for a range of genetic diseases prenatally, with minimal risk to the fetus...
24 October 2011 - by Julianna Photopoulos 
A new prenatal test that can detect Down's syndrome by using a sample of the mother's blood was launched in twenty US cities last Monday....
13 December 2010 - by Julianna Photopoulos 
Scientists have scanned the entire DNA of an unborn child from the mother's blood sample for the first time to safely check for genetic disorders...
1 November 2010 - by MacKenna Roberts 
The European Society of Human Reproduction and Embryology (ESHRE) has published an updated set of best practice guidelines for fertility clinics on the use of preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS) techniques...
16 August 2010 - by Dr Lux Fatimathas 
Newborn babies showing signs of liver disorders will be screened for 92 genetic conditions, as part of a trial launching next month at Birmingham Children's Hospital. Newborns will be screened for multiple conditions with a single test using gene chip technology....
29 September 2008 - by Ailsa Stevens 
A decade ago, it was found that the blood of pregnant women contains DNA from the fetus. The discovery of this 'free fetal DNA' (ffDNA) has led to the development of non-invasive prenatal diagnosis, where genetic characteristics of the fetus can be analysed a mere few weeks into pregnancy by...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.